De Sire et al., 2019 - Google Patents
Nutritional supplementation in hip fracture sarcopenic patients: a narrative review.De Sire et al., 2019
- Document ID
- 5370610653149254918
- Author
- De Sire A
- Invernizzi M
- Lippi L
- Curci C
- Cisari C
- Iolascon G
- Publication year
- Publication venue
- Clinical Cases in Mineral & Bone Metabolism
External Links
Snippet
In light of the progressive aging of the population the number of hip fractures is expected to be higher with resulting increased mortality, disability and medical costs. Nutritional interventions and supplementation in hip fractured patients, and in particular in sarcopenic …
- 206010020100 Hip fracture 0 title abstract description 27
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
Publication | Publication Date | Title |
---|---|---|
De Sire et al. | Nutritional supplementation in hip fracture sarcopenic patients: a narrative review. | |
Shin et al. | Testosterone and sarcopenia | |
Harrington et al. | Update on the evaluation and treatment of osteogenesis imperfecta | |
Rizzoli et al. | The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) | |
Body et al. | Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club | |
Morley et al. | Nutritional recommendations for the management of sarcopenia | |
Botella-Carretero et al. | Perioperative oral nutritional supplements in normally or mildly undernourished geriatric patients submitted to surgery for hip fracture: a randomized clinical trial | |
US10537598B2 (en) | Selection and use of lactic acid bacteria preventing bone loss in mammals | |
Rondanelli et al. | Update on nutrients involved in maintaining healthy bone | |
Rizzoli | Nutrition and sarcopenia | |
Mancilla et al. | Teriparatide as a systemic treatment for lower extremity nonunion fractures: a case series | |
Eckstein et al. | Association between metabolic syndrome and bone mineral density-data from the Berlin Aging Study II (BASE-II) | |
Del Puente et al. | Fragility fractures in patients with psoriatic arthritis | |
Oteri et al. | Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgery | |
Wright | Osteoporosis in men | |
Abboud et al. | Gut microbiome, probiotics and bone: An updated mini review | |
Srinivasan et al. | In vivo efficacy of calcium phosphate‐based synthetic‐bone‐mineral on bone loss resulting from estrogen and mineral deficiencies | |
Groenendijk et al. | Discussion on protein recommendations for supporting muscle and bone health in older adults: a mini review | |
Cherian et al. | Prevalence of vitamin D deficiency in patients presenting with an orthopaedic trauma at a tertiary centre in south India-implications and protocols for replacement therapy | |
Waters | Nonpharmacologic intervention for osteosarcopenia | |
Ilacqua et al. | Lifestyle and Osteoporosis Risk in Men (Physical Activity, Diet, Alcohol Abuse) | |
de Oliveira Gomes | Major considerations and outcomes of clinical trials of vitamin D in athlete performance: a systematic review | |
Krogh et al. | Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training | |
Middleton et al. | Vitamin D deficiency: A simple algorithm employing weekly administration of 50,000 áIU of vitamin D | |
Ivanova et al. | Prophylactics of Osteoporosis |